Galmed Pharmaceuticals Ltd. buy Bank of America Co.
Start price
07.11.25
/
50%
€6.40
Target price
07.11.26
€78.87
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 07.11.26. The prediction end date can be changed by Bank_of_America_Co_ at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical (NYSE:GMED) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $91.00 price target on the stock, up previously from $65.00.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
06.11.24
06.11.24
€74.68
06.11.25
06.11.25
-
07.11.25
07.11.25
